TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients. Ortiz-Otero N, Marshall JR, Glenn A, Matloubieh J, et al. BMC Cancer 2021;21:898.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ortiz-Otero N, Marshall JR, Glenn A, Matloubieh J, et al. TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients. BMC Cancer 2021;21:898.
PMID: 34362331